Stay updated on Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A recruitment status note 'No longer looking for participants' was added to the study page. The page also gained new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a UI header change for Intervention/Treatment and an updated revision tag (from v3.5.5 to v3.6.0).
    Difference
    0.2%
    Check dated 2026-06-16T00:38:47.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A new page revision entry (v3.5.5) was added and the previous revision (v3.5.4) was removed, indicating a minor update to the page's documentation.
    Difference
    0.0%
    Check dated 2026-06-09T00:37:55.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page adds 'Multiple myeloma' and a 'related topics' section (including MedlinePlus Genetics) to broaden disease context, and includes a new MAIA-related publication citation in the Publications list.
    Difference
    0.1%
    Check dated 2026-06-01T19:50:06.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.4, replacing the previous v3.5.3; this indicates a maintenance update rather than a change to study details.
    Difference
    0.0%
    Check dated 2026-05-18T13:31:07.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A new publication citation was added to the publications list, referencing a 2026 Blood Advances article on infections in patients treated with daratumumab for newly diagnosed multiple myeloma. This addition provides contextual scholarly context without altering the study’s core information.
    Difference
    0.0%
    Check dated 2026-05-11T12:14:02.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page’s UI/version marker was updated to **Revision: v3.5.3** and some related navigation/topic text from a prior revision was removed.
    Difference
    0.1%
    Check dated 2026-04-27T07:50:58.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.